IMAGE DESCRIPTION: An image of a doctor prescribing medication with a circular image of Dr Charles Shepherd, MEA Hon. Medical Adviser. Title: Feedback required on medication for pain in ME/CFS. The MEA logo (bottom right)

Feedback required on medication for pain in ME/CFS

The ME Association's medical adviser Dr Charles Shepherd is currently updating the MEA information leaflet on Gabapentin/Neurontin.

Gabapentin/Neurontin as a management option for moderate or severe pain in ME/CFS. This is a prescription-only drug that is sometimes used to treat more severe or persistent pain, especially neve/neuropathic pain – which has a shooting or burning quality 

Gabapentin does, however, have a number of side effects – including fatigue, muscle pain and weakness, dizziness, memory loss – which can obviously cause problems when used in ME/CFS

So the feedback from people with ME/CFS that we have obtained over the years has been very mixed.  Some people report gaining benefit and without any significant problems with side-effects.  However, a significant proportion of people have been unable to tolerate this drug due to the side-effects

The aim of this survey is to obtain some up to date patient evidence from people who have been, or are currently using gabapentin

Thanks for your assistance!

Dr Charles Shepherd,
Trustee and Hon. Medical Adviser to the ME Association,
Member of the 2018-2021 NICE guideline on ME/CFS committee,
Member of the 2002 Chief Medical Officer's Working Group on ME/CFS

Charles Shepherd

Please complete this short survey:

If you are using, or have been using gabapentin/Neurontin for pain management, what is your overall experience?

Further information

Shopping Basket
Scroll to Top